Home › Trial NCT00064610
Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancer
- Trial IDNCT00064610
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorMillennium Pharmaceuticals, Inc.
- Enrollment102
- Start date2002-12
- ConditionsProstatic Neoplasms
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.